Polyclonal serum-free light chains elevation in HIV-infected patients

Area of Science:

• Immunology
• Infectious Diseases
• Clinical Biomarkers

Background:

• Human Immunodeficiency Virus (HIV) infection is a chronic condition requiring continuous monitoring of disease progression and patient health.
• Established prognostic biomarkers for HIV include CD4 cell count, viral load, and duration of viral suppression.
• Polyclonal free light chains (FLCs) are emerging biomarkers with potential clinical relevance in various inflammatory and infectious conditions.

Purpose of the Study:

• To investigate the association between polyclonal serum-free light chains (FLCs) and established prognostic biomarkers in individuals with HIV infection.
• To determine if elevated polyclonal FLCs correlate with key indicators of HIV disease status and progression.

Main Methods:

• Serum samples from 182 HIV-infected patients were analyzed.
• Patients were part of the Italian Cohort of Antiretroviral Naive Patients (ICONA) foundation cohort.
• Levels of polyclonal serum-FLCs were measured and compared against standard HIV prognostic markers.

Main Results:

• Polyclonal serum-FLCs above the upper normal limit were strongly correlated with advancing age in HIV-infected patients.
• Elevated polyclonal FLCs were associated with a shorter time of undetectable HIV viremia.
• Higher viral load and lower CD4 cell counts at the time of sample collection were also significantly correlated with increased polyclonal FLC levels.

Conclusions:

• Polyclonal serum-FLCs are significantly associated with key prognostic indicators in HIV infection.
• Elevated polyclonal FLCs may serve as a potential biomarker reflecting disease activity and immune status in HIV-positive individuals.
• Further research is warranted to explore the clinical utility of polyclonal FLCs in managing HIV infection.